BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37587906)

  • 1. Molecular analysis of dUTPase of
    Sisodia R; Sarmadhikari D; Mazumdar PA; Asthana S; Madhurantakam C
    J Biomol Struct Dyn; 2023 Aug; ():1-26. PubMed ID: 37587906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic level and structural understanding of natural ligands inhibiting
    Sunder Raj D; Kesavan DK; Kottaisamy CPD; Kumar VP; Hopper W; Sankaran U
    J Biomol Struct Dyn; 2023 May; 41(8):3440-3461. PubMed ID: 35293845
    [No Abstract]   [Full Text] [Related]  

  • 3. In silico identification and analysis of potential inhibitors for acid phosphatase, HppA from Helicobacter pylori.
    Sisodia R; Mazumdar PA; Madhurantakam C
    J Mol Recognit; 2023 Sep; 36(9):e3049. PubMed ID: 37553866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immucillin analogue natural compounds to inhibit
    Raj DS; Kottaisamy CPD; Hopper W; Sankaran U
    In Silico Pharmacol; 2021; 9(1):22. PubMed ID: 33786292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Identification of a Novel Anti-tuberculosis Compound That Targets Deoxyuridine 5'-Triphosphate Nucleotidohydrolase.
    Zhang Y; Zhang H; Chen Y; Qiao L; Han Y; Lin Y; Si S; Jiang JD
    Front Microbiol; 2021; 12():757914. PubMed ID: 34707597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains.
    Pasala C; Katari SK; Nalamolu RM; Bitla AR; Amineni U
    J Mol Graph Model; 2019 Nov; 92():167-179. PubMed ID: 31376734
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chaudhary B; Sisodia R; Sarmadhikari D; Mazumdar PA; Asthana S; Madhurantakam C
    J Biomol Struct Dyn; 2024 May; ():1-26. PubMed ID: 38726567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and potent inhibitors for dihydropteroate synthase of
    Satuluri SH; Katari SK; Pasala C; Amineni U
    J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
    Mandal RS; Das S
    J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening and molecular dynamics simulations of natural products targeting LuxS/AI-2 system as a novel antibacterial strategy for antibiotic resistance in
    Ashok AK; Gnanasekaran TS; Santosh Kumar HS; Srikanth K; Prakash N; Gollapalli P
    J Biomol Struct Dyn; 2024 Apr; 42(6):2913-2928. PubMed ID: 37160706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential inhibitors of
    Kamera S; Sharma VK; Prasad V B; Garlapati A
    J Biomol Struct Dyn; 2023 Aug; ():1-15. PubMed ID: 37526169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
    Chahal V; Kakkar R
    J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of promising anti-DNA gyrase antibacterial compounds using
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2020 Apr; 38(6):1798-1809. PubMed ID: 31084271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
    Tabassum H; Ahmad IZ
    Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Virtual Screening of Helicobacter pylori SecA Inhibitors.
    Jian T; Su Q; Liu Y; Seoh HK; Houghton JE; Tai PC; Huang X
    IEEE Trans Nanobioscience; 2023 Oct; 22(4):933-942. PubMed ID: 37030876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer.
    Backer N; Kumar A; Singh AK; Singh H; Narasimhan B; Kumar P
    Drug Discov Today; 2024 Jan; 29(1):103853. PubMed ID: 38070703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of natural marine compounds as potential inhibitors of CDK2 using molecular docking and molecular dynamics simulation approach.
    Ahmad B; Saeed A; Castrosanto MA; Amir Zia M; Farooq U; Abbas Z; Khan S
    J Biomol Struct Dyn; 2023; 41(17):8506-8516. PubMed ID: 36300512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.